Answers are grounded in this paper and cite their sources.
Background: Focal pancreatic lesions present a significant diagnostic challenge. Multi-detector computed tomography (MDCT) is the primary imaging modality for their evaluation. Accurate characterization and resectability assessment are critical for optimal management. Aim: To determine the diagnostic accuracy of multi-detector contrast-enhanced CT in evaluation of focal pancreatic lesions with histopathological correlation. Materials and Methods: This prospective observational study was conducted at the Department of Radio-Diagnosis, Mahatma Gandhi Medical College & Hospital, Jaipur, from April 2024 to September 2025. Eighty-six patients with focal pancreatic lesions on MDCT underwent histopathological confirmation. MDCT findings were correlated with histopathology to determine sensitivity, specificity, PPV, NPV, and diagnostic accuracy. Results: The mean age was 58.70 ± 10.20 years with male predominance (54.65%). Malignant lesions constituted 83.72% (72/86), with pancreatic ductal adenocarcinoma being most common (52.33%). The pancreatic head was the most common location (44.19%). MDCT demonstrated sensitivity of 91.67%, specificity of 85.71%, PPV of 97.06%, NPV of 66.67%, and overall diagnostic accuracy of 90.70%. Among 72 malignant cases, 58 (80.56%) were resectable and 14 (19.44%) were unresectable. Vascular encasement (50%) was the most common cause of unresectability. Conclusion: MDCT is a highly accurate imaging modality for characterisation of focal pancreatic lesions, with diagnostic performance comparable to international literature. It provides comprehensive evaluation including lesion detection, characterisation, vascular assessment, and resectability determination.
No takes yet. Share an insight, caveat, or question.
Dhakar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: